News
2d
GlobalData on MSNExact Sciences expands partnership with Humana to improve colorectal cancer screeningThe Cologuard Plus test is being offered as an in-network service to eligible Humana Medicare Advantage members.
Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced an expanded ...
Louisville, Ky.-based Humana contracted with Madison, Wis.-based Exact Sciences Corp. to cover Cologuard — a colon cancer test — as an in-network service for its members.
Here are four updates on gastroenterology and endoscopy companies. London-based Lumendi received 510(k) clearance from the FDA for its DiLumen, an endoscopic accessory. Laval, Quebec-based Valeant ...
Fact checked by Nick Blackmer Cologuard is getting an upgrade soon. An updated at-home screening test, called Cologuard Plus, is expected to be available in June 2025. Cologuard Plus is a more ...
About Cologuard Results from Exact Sciences' prospective, 90-site, point-in-time, 10,000-patient pivotal trial, DeeP-C, were published in the New England Journal of Medicine in March 2014.
The updated Cologuard Plus test also has reported a higher specificity of 94 percent. That means it is also very good at identifying who doesn’t have colorectal cancer. The original Cologuard ...
Ten years after first collecting an FDA approval, it’s time for version number two. Exact Sciences has received an agency green light for Cologuard Plus, the next generation of its mainstay, at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results